Cefprozil
سفپروزیل
🦠 Antiinfectives For Systemic UseSecond-generation cephalosporin
Market / country: 🇺🇸 USA
Cefzil (US)
🧮 Dose calculator
Acute otitis media · Regimen source: FDA Cefprozil susp. · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Allergy to cephalosporins. FDA Cefprozil susp. · Contraindications
Renal adjustment
- • eGFR < 30: CrCl 0–29: 50% of the standard dose at the standard interval; give after dialysis. FDA Cefprozil susp. · Dosage and Administration
Formulations
- 125 mg / 5 mL — suspension 🇺🇸 USA FDA Cefprozil susp. · How Supplied
- 250 mg / 5 mL — suspension 🇺🇸 USA FDA Cefprozil susp. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Cefprozil susp. · Pregnancy
“Teratogenic Effects: Pregnancy Category B Reproduction studies have been performed in rabbits, mice, and rats using oral doses of cefprozil of 0.8, 8.5, and 18.5 times the maximum daily human dose (1000 mg) based upon mg/m 2 , and have revealed no harm to the fetus.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Cefprozil susp. · Nursing Mothers
“Caution should be exercised when cefprozil is administered to a nursing woman, since the effect of cefprozil on nursing infants is unknown.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Cefprozil susp. · Pediatric Use
“( See INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION .) The safety and effectiveness of cefprozil in the treatment of otitis media have been established in the age groups 6 months to 12 years.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Cefprozil susp. · Geriatric Use
“Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals to the effects of cefprozil cannot be excluded (see CLINICAL PHARMACOLOGY ).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA065381
- DailyMed (FDA label)FDA Cefprozil susp.
- MedlinePlus (NIH)Cefprozil
- WHO ATC/DDDJ01DC10
- Darooyab (Iran)Cefprozil
🇮🇷 Not found in Iran list Darooyab · G-343/Cefprozil
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Cefprozil susp. · How SuppliedFDA Cefprozil susp. · Dosage and AdministrationFDA Cefprozil susp. · ContraindicationsFDA Cefprozil susp. · PregnancyFDA Cefprozil susp. · Nursing MothersFDA Cefprozil susp. · Pediatric UseFDA Cefprozil susp. · Geriatric UseFDA Cefprozil susp. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-343/Cefprozil
- Clinical review⚠ Unverified